Neoadjuvant Radiochemotherapy for Borderline and Locally Advanced Pancreatic Cancer Is a Promising Strategy to Improve Surgical Resection Rates and Outcome

被引：0
|
作者：
Vendrely, V. [1 ]
Pouypoudat, C. [1 ]
Buscail, E. [2 ]
Cossin, S. [3 ]
Cassinotto, C. [1 ]
Terrebonne, E. [1 ]
Blanc, J. F. [4 ]
Dupin, C. [1 ]
Laurent, C.
Dabernat, S. [5 ]
Chiche, L. [1 ]
机构：
[1] CHU Bordeaux, Haut Leveque Hosp, Pessac, France
[2] CHU Bordeaux, Bordeaux, France
[3] ISPED, Bordeaux, France
[4] CHU Bordeaux, St Andre Hosp, Bordeaux, France
[5] INSERM, Bordeaux, France
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2439
引用
收藏
页码：E180 / E180
页数：1
相关论文
共 50 条
  • [41] Sequential neoadjuvant chemotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma
    Paluri, Ravi Kumar
    McCormack, Michael Joseph, Jr.
    Neal, Austin
    Moore, Stacie
    Shen, Perry
    Clark, Clancy
    Ogburn, Olivia
    Dressler, Emily Van Meter
    Deep, Gagan
    Greissinger, April
    Mcilwain, Laura
    Yacoub, George
    Sirkisoon, Sherona
    Lima, Caio Max Sao Pedro Rocha
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapy
    Wijetunga, Asanka R.
    Chua, Terence C.
    Nahm, Christopher B.
    Pavlakis, Nick
    Clarke, Stephen
    Chan, David L.
    Diakos, Connie
    Maloney, Sarah
    Ashrafi-Zadeh, Amir
    Kneebone, Andrew
    Hruby, George
    Jamieson, Nigel B.
    Gill, Anthony
    Mittal, Anubhav
    Samra, Jaswinder S.
    EJSO, 2021, 47 (10): : 2543 - 2550
  • [43] The Role of Neoadjuvant Chemotherapy in Elderly Patients with Borderline or Locally Advanced Pancreatic Cancer: Is it Safe and Feasible?
    Oba, A.
    Lieu, C.
    Meguid, C.
    Gleisner, A.
    Ahrendt, S.
    Leong, S.
    Messersmith, W.
    Schulick, R.
    Del Chairo, M.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S121 - S121
  • [44] ASO Visual Abstract: Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
    Alva-Ruiz, Roberto
    Yohanathan, Lavanya
    Yonkus, Jennifer A.
    Abdelrahman, Amro M.
    Gregory, Lindsey A.
    Halfdanarson, Thorvadur R.
    Mahipal, Amit
    McWilliams, Robert R.
    Ma, Wen Wee
    Hallemeier, Christopher L.
    Graham, Rondell P.
    Grotz, Travis E.
    Smoot, Rory L.
    Cleary, Sean P.
    Nagorney, David M.
    Kendrick, Michael L.
    Truty, Mark J.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (03) : 1594 - 1595
  • [45] Surgical therapy for locally advanced non-resectable pancreatic cancer following preoperative radiochemotherapy
    Rau, HG
    Wichmann, MW
    Wilkowski, R
    Heinemann, V
    Sackmann, M
    Helmberger, T
    Dühmke, E
    Schildberg, FW
    CHIRURG, 2002, 73 (02): : 132 - 137
  • [46] Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX
    Choi, Young Hoon
    Lee, Sang Hyub
    You, Min Su
    Shin, Bang Sup
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    Kwon, Wooil
    Jang, Jin-Young
    Kim, Sun-Whe
    GUT AND LIVER, 2021, 15 (02) : 315 - 323
  • [47] Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis
    Choi, Jin G.
    Nipp, Ryan D.
    Tramontano, Angela
    Ali, Ayman
    Zhan, Tiannan
    Pandharipande, Pari
    Dowling, Emily C.
    Ferrone, Cristina R.
    Hong, Theodore S.
    Schrag, Deborah
    Fernandez-Del Castillo, Carlos
    Ryan, David P.
    Kong, Chung Yin
    Hur, Chin
    ONCOLOGIST, 2019, 24 (07): : 945 - 954
  • [48] The role of neoadjuvant chemotherapy in elderly patients with borderline or locally advanced pancreatic cancer: Is it safe and feasible?
    Oba, Atsushi
    Lieu, Christopher Hanyoung
    Meguid, Cheryl Lauren
    Davis, Sarah Lindsey
    Leal, Alexis Diane
    Purcell, Tom
    King, Gentry Teng
    Goodman, Karyn A.
    Schefter, Tracey E.
    Gleisner, Ana Luiza
    Ahrendt, Steven Arthur
    Leong, Stephen
    Messersmith, Wells A.
    Shulick, Richard D.
    Del Chiaro, Marco
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [49] Comment on "Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer''
    Kirkegard, Jakob
    Mortensen, Frank Viborg
    Cronin-Fenton, Deirdre
    ANNALS OF SURGERY, 2019, 270 (06) : E138 - E139
  • [50] PROGNOSTIC FACTORS FOR PATIENTS WITH BORDERLINE RESECTABLE OR LOCALLY ADVANCED PANCREATIC CANCER RECEIVING NEOADJUVANT FOLFIRINOX
    Choi, Young Hoon
    Lee, Sang Hyub
    You, Min Su
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2019, 156 (06) : S321 - S322
12345